Literature DB >> 25961436

Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.

Stephen A Goutman1, Eva L Feldman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25961436      PMCID： PMC5499507          DOI： 10.1001/jamaneurol.2014.4275

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  3 in total

Review 1.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 2.  Predicting success: optimizing phase II ALS trials for the transition to phase III.

Authors:  James D Berry; Merit E Cudkowicz; Jeremy M Shefner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-03       Impact factor: 4.092

3.  Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.

Authors:  Eva L Feldman; Nicholas M Boulis; Junguk Hur; Karl Johe; Seward B Rutkove; Thais Federici; Meraida Polak; Jane Bordeau; Stacey A Sakowski; Jonathan D Glass
Journal:  Ann Neurol       Date:  2014-03-07       Impact factor: 10.422
  3 in total
  4 in total

1.  High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Jonathan Boss; Adam Patterson; Bhramar Mukherjee; Stuart Batterman; Eva L Feldman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-02-13       Impact factor: 10.154

2.  Association of Environmental Toxins With Amyotrophic Lateral Sclerosis.

Authors:  Feng-Chiao Su; Stephen A Goutman; Sergey Chernyak; Bhramar Mukherjee; Brian C Callaghan; Stuart Batterman; Eva L Feldman
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

3.  Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS.

Authors:  Ryan D Jacobson; Stephen A Goutman; Brian C Callaghan
Journal:  Neurology       Date:  2016-03-29       Impact factor: 9.910

4.  Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  BMC Neurol       Date:  2017-04-17       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.